Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
Hammerstingl
R
R
Department of Radiology, Humboldt University of Berlin, Rudolf Virchow Hospital, Germany.
Vogl
T J
TJ
Schwarz
W
W
Kümmel
S
S
Balzer
T
T
Neuhaus
P
P
Felix
R
R
D006528:Carcinoma, Hepatocellular / Q000175:diagnosis*; D018281:Cholangiocarcinoma / Q000175:diagnosis; D003287:Contrast Media / Q000008:administration & dosage; D003911:Dextrans; D052203:Ferrosoferric Oxide; D005682:Gadolinium; D006391:Hemangioma / Q000175:diagnosis; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000556:secondary; D008115:Liver Regeneration; D008223:Lymphoma / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D010087:Oxides / Q000008:administration & dosage; D011446:Prospective Studies; D013535:Suspensions
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D013535:Suspensions; D005682:Gadolinium; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide